Halberd Corporation 2023 Year-End CEO Update and 2024 Goals [Yahoo! Finance]
HALBERD CORP (HALB)
Company Research
Source: Yahoo! Finance
2023 ACHIEVEMENTS Halberd received from the CDC two sets of antibiotic resistant bacteria and fungi (a total of 60 samples) on which to test its proprietary laser eradication methodology. Testing at Youngstown State University (YSU) successfully eradicated every sample of the various strains of E. coli, Candida auris, Shigella, and Klebsiella pneumoniae, which are linked to numerous infections, including pneumonia, meningitis, digestive tract infections, etc. Eradication of these bacteria was achieved by using as little as 10% of the laser power used in the initial eradication testing. The ability to achieve the same level of antigen eradication at a fraction of the power further reduces potential collateral damage to surrounding constituents in blood or CSF Halberd contracted Mississippi State University (MSU) to develop and conduct a preclinical testing protocol for Halberd's patent-pending nasal spray to safely counteract the effects of Traumatic Brain Injury (TBI). This t
Show less
Read more
Impact Snapshot
Event Time:
HALB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HALB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HALB alerts
High impacting HALBERD CORP news events
Weekly update
A roundup of the hottest topics
HALB
News
- Halberd's Patented Drug, LDN+, the Subject of a Limited Clinical Trial Under an Innovative Four-Company Cooperative Research and Development (CRADA) Contract [Yahoo! Finance]Yahoo! Finance
- Halberd's Patented Drug, LDN+, the Subject of a Limited Clinical Trial Under an Innovative Four-Company Cooperative Research and Development (CRADA) ContractAccesswire
- Halberd and Mississippi State University to Commence Stage II Advanced TBI Nasal Spray Testing [Yahoo! Finance]Yahoo! Finance
- Halberd and Mississippi State University to Commence Stage II Advanced TBI Nasal Spray TestingAccesswire
- Halberd's Top Executives Join Forces with Athena GTX CEO Mark Darrah Unveiling 2024 Powerful Partnership Outlook on "The Street Reports Podcast" [Yahoo! Finance]Yahoo! Finance